TARGETED TGF BETA INHIBITION

This invention relates generally to bifunctional molecules including (a) a TGFβRII or fragment thereof capable of binding TGFβ and (b) an antibody, or antigen binding fragment thereof, that binds to an immune checkpoint protein, such as Programmed Death Ligand 1 (PD-L1), uses of such molecules (e.g....

Full description

Saved in:
Bibliographic Details
Main Author LO, Kin-Ming
Format Patent
LanguageEnglish
French
German
Published 21.12.2016
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

Abstract This invention relates generally to bifunctional molecules including (a) a TGFβRII or fragment thereof capable of binding TGFβ and (b) an antibody, or antigen binding fragment thereof, that binds to an immune checkpoint protein, such as Programmed Death Ligand 1 (PD-L1), uses of such molecules (e.g., for treating cancer), and methods of making such molecules.
AbstractList This invention relates generally to bifunctional molecules including (a) a TGFβRII or fragment thereof capable of binding TGFβ and (b) an antibody, or antigen binding fragment thereof, that binds to an immune checkpoint protein, such as Programmed Death Ligand 1 (PD-L1), uses of such molecules (e.g., for treating cancer), and methods of making such molecules.
Author LO, Kin-Ming
Author_xml – fullname: LO, Kin-Ming
BookMark eNrjYmDJy89L5WSQCXEMcncNcXVRCHF3U3ByDXFU8PTz8HTyDPH09-NhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAcaGBqZGJmaORsZEKAEA8VMh7w
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate INHIBITION CIBLEE DE FACTEUR DE CROISSANCE DE TRANSFORMATION BÊTA (TGF )
GEZIELTE TGF-BETA-HEMMUNG
ExternalDocumentID EP3105246A2
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3105246A23
IEDL.DBID EVB
IngestDate Fri Jul 19 12:48:23 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3105246A23
Notes Application Number: EP20150717097
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161221&DB=EPODOC&CC=EP&NR=3105246A2
ParticipantIDs epo_espacenet_EP3105246A2
PublicationCentury 2000
PublicationDate 20161221
PublicationDateYYYYMMDD 2016-12-21
PublicationDate_xml – month: 12
  year: 2016
  text: 20161221
  day: 21
PublicationDecade 2010
PublicationYear 2016
RelatedCompanies Merck Patent GmbH
RelatedCompanies_xml – name: Merck Patent GmbH
Score 3.057324
Snippet This invention relates generally to bifunctional molecules including (a) a TGFβRII or fragment thereof capable of binding TGFβ and (b) an antibody, or antigen...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Title TARGETED TGF BETA INHIBITION
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20161221&DB=EPODOC&locale=&CC=EP&NR=3105246A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbG2Sg6SW9C8NsmhSB6bJkLTUKL0VtzNFnqpxUb8-51d0upFb8Mu7GNgvnnuLMCDjya0IL5rLEngGQ4TiIMIlkbNeW0_cSJ8ITO6k4Jkr87L3J13YLV_C6P6hH6r5ogoURzlvVF4vfkJYiWqtnL7yFY49PGcVqNEb71jNF8sy9STaETLaTKN9ThGSi9mMo7tWg4JEa2PpBUt2-zTt0g-Stn81ijpORyXuNi6uYCOWPfgNN5_vNaDk0mb70ayFb3tJQyrcDamiDNaNU61iFahlhdZHuUyxnQFWkqrODNwm8XhSgtaHg5kX0MXPX1xA5qHvhB3BYLUu3BqnwXc4sxE_plL4dkB6UP_z2Vu_5kbwJnkjazCsMwhdJvPL3GHurRh94oLOzhxdKQ
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2K1ag6SW9C8NsmhSJ5NtElDWaW3YDZb6KUtNuLfdzak1Yvehl3Yx8B889xZgHsbTWhObFNZEMdSjJIjDiJYKhVjlf7ICLe5yOimGYlfjee5Oe_AcvcWpukT-tU0R0SJYijvdYPXm58gVtDUVm4fyiUOrZ8iOgrk1jtG80XTVDnwRmE-Daa-7PtIydlMxLFNzSAuovWBJZrzCsvpzROPUja_NUp0Aoc5LraqT6HDV33o-buP1_pwlLb5biRb0duewZC6s3GIOCPRcSR5IXWlJIsTLxExpnOQopD6sYLbFPsrFWG-P5B-AV309PklSBb6QszkCFLv3Kjs0mEaK1Xkn7rglu6QAQz-XObqn7k76MU0nRSTJHu5hmPBJ1GRoalD6NYfn_wG9Wpd3jYc-QbUn3eR
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TARGETED+TGF+BETA+INHIBITION&rft.inventor=LO%2C+Kin-Ming&rft.date=2016-12-21&rft.externalDBID=A2&rft.externalDocID=EP3105246A2